| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 09/04/2002 | EP0724587B1 Ring-expanded nucleosides and nucleotides |
| 09/04/2002 | CN1367646A Ectoparasiticidal aqueous suspension formulations of Spinosyn |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2002 | US6444648 Preventing and/or treating disease caused by leishmaniasis infectious species |
| 09/03/2002 | CA2263203C 3,6-ketal and enol ether macrolide antibiotics |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | WO2002066061A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 08/29/2002 | WO2002066048A1 Crystal modification of a cyclic depsipeptide having improved strength |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2000063245A9 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
| 08/29/2002 | US20020119961 Bridged piperazine derivatives |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | CA2438682A1 Antibodies that bind both bcma and taci |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2436832A1 Crystal form of a cyclic depsipeptide having improved activity |
| 08/29/2002 | CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/28/2002 | EP1234821A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234584A1 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 08/28/2002 | EP1234025A1 Human enzymes of the metalloprotease family |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 08/28/2002 | EP1233952A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
| 08/28/2002 | EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 08/28/2002 | EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 08/28/2002 | EP1233779A2 New uses of suppressive macrophage activation factors |
| 08/28/2002 | EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 08/28/2002 | CN1365672A Nano medicine for treating baby obesity and its preparing process |
| 08/27/2002 | US6441030 3-phenyl-pyrones |
| 08/27/2002 | US6440936 Anti-protozoan methods and materials |
| 08/27/2002 | US6440408 Method of treatment |
| 08/22/2002 | WO2002064795A2 Putative human enzymes |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/22/2002 | WO2002033050A3 Methods and compositions for promoting the maturation of monocytes |
| 08/22/2002 | WO2001087328A3 Interleukin-1 inhibitors in the treatment of diseases |
| 08/22/2002 | WO2001085204A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001085203A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115644 Tetracycline compounds for treatment of Cryptosporidium parvum related disorders |
| 08/22/2002 | US20020115621 Macrolide antibiotics |
| 08/22/2002 | US20020114844 Particle formation methods and their products |
| 08/22/2002 | US20020114777 Cationic quaternery ammonium containing polymers for treatment of gastrointestinal disorders; cytotoxicity |
| 08/22/2002 | CA2438215A1 Putative human enzymes |
| 08/22/2002 | CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/21/2002 | EP1232748A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 08/21/2002 | EP1232180A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 08/21/2002 | EP1231924A2 Treatment of systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 08/21/2002 | EP1231923A1 Protease inhibitors |
| 08/21/2002 | EP1231922A1 Protease inhibitors |
| 08/21/2002 | EP1231921A1 Protease inhibitors |
| 08/21/2002 | EP1231916A2 Use of indirubine derivatives for making medicines |
| 08/21/2002 | EP1231912A1 Injectable preparation for controlling fish live comprising benzoyl urea derivatives |
| 08/21/2002 | EP1041991A4 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 08/21/2002 | EP0637203B1 Regulation of the immune system |
| 08/21/2002 | CN1365278A Water soluble trioxanes as potent and safe anti-malarial agents |
| 08/20/2002 | US6436984 Melatonergic drugs that release nitrogen oxide and melatonin, used for prophylaxis of cardiovascular/nervous system, muscular disorders, antiischemic/inflammatory agents, reperfusion injuries, anemia and alzheimer's disease |
| 08/20/2002 | US6436951 Camptothecin tetracyclic analogues, preparation, method, applications as medicines and pharmaceutical compositions containing them |
| 08/20/2002 | US6436935 Paste with polyacrylic acid |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | US6436386 Hydroxyapatite-targeting poly (ethylene glycol) and related polymers |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062326A1 Parasiticidal compositions and methods of use |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002011757A3 Compositions and methods for inhibiting transmission of malaria |
| 08/15/2002 | WO2002002050A3 Prevention and treatment of mycoplasma-associated diseases |
| 08/15/2002 | WO2001092321A3 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 08/15/2002 | US20020111352 Parasiticides |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/14/2002 | EP1230268A2 Heteroclitic analogs of class i epitopes |
| 08/14/2002 | EP1230239A1 Pesticidal aminoheterocyclamide compounds |
| 08/14/2002 | EP1230235A1 Compounds with antibacterial and antiparasitic properties |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229791A2 Active ingredient combination having insecticidal and acaricidal characteristics |
| 08/14/2002 | EP0892642B1 Use in a composition of an extract of at least one labiate of the genus rosmarinarus, cultured in vitro |
| 08/14/2002 | EP0703916B1 14-substituted marcfortines and derivatives useful as antiparasitic agents |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/13/2002 | US6432935 Synergistic mixture of antibiotic, sulfadimidine and fungicide |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060856A1 Novel quaternary ammonium salt compounds, process for producing the same and use thereof |
| 08/08/2002 | WO2002060450A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | WO2002060258A1 Fish anthelmintics and anthelmintic method |
| 08/08/2002 | WO2002060257A1 Pharmaceutical composition containing aminoacetonitril compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals |
| 08/08/2002 | WO2002046208A3 Method of producing biospecific molecules by protein trans-splicing |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001095934A3 The use of plant oil-bodies in vaccine delivery systems |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001091536A3 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 08/08/2002 | WO2001023604A3 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 08/08/2002 | US20020107393 The crystalline monohydrate form provides increased stability over the anhydrous form. |
| 08/08/2002 | US20020107266 Amides used particularly in the treatment, prevention or amelioration of one or more symptoms of malaria or Chagas' disease; inhibiting the activity of falcipain or cruzain |